 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - UroGen Pharma Ltd. (URGN)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-08-14 Sale | 2019-08-16 3:38 pm | UroGen Pharma Ltd. | URGN | Mullennix Stephen COO | 608 | $31.65 | $19,243 | 6,532 (Direct) | View |
| 2019-08-20 Sale | 2019-08-22 1:31 pm | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO | 1,416 | $33.07 | $46,827 | 2,751 (Direct) | View |
| 2019-09-04 Sale | 2019-09-06 09:27 am | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 343 | $33.92 | $11,635 | 6,007 (Direct) | View |
| 2019-11-14 Sale | 2019-11-18 4:04 pm | UroGen Pharma Ltd. | URGN | Mullennix Stephen COO | 608 | $26 | $15,806 | 7,683 (Direct) | View |
| 2019-11-15 Purchase | 2019-11-18 7:32 pm | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. CEO | 1,548 | $26 | $40,248 | 1,548 (Direct) | View |
| 2019-11-19 Purchase | 2019-11-21 8:49 pm | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 1,960 | $28.17 | $55,213 | 7,967 (Indirect) | View |
| 2019-11-20 Sale | 2019-11-22 1:29 pm | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO | 354 | $28.41 | $10,057 | 3,439 (Direct) | View |
| 2019-11-20 Purchase | 2019-11-22 1:35 pm | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. CEO | 7,470 | $28 | $209,160 | 9,018 (Direct) | View |
| 2019-11-21 Purchase | 2019-11-22 3:34 pm | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. CEO | 7,530 | $28 | $210,840 | 16,548 (Direct) | View |
| 2020-01-26 Sale | 2020-01-28 5:10 pm | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 322 | $29.15 | $9,386 | 9,177 (Direct) | View |
| 2020-01-26 Sale | 2020-01-28 5:14 pm | UroGen Pharma Ltd. | URGN | Mullennix Stephen COO | 684 | $29.26 | $20,014 | 8,665 (Direct) | View |
| 2020-01-26 Sale | 2020-01-28 5:15 pm | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO | 667 | $29.28 | $19,530 | 4,438 (Direct) | View |
| 2020-02-14 Sale | 2020-02-18 2:33 pm | UroGen Pharma Ltd. | URGN | Mullennix Stephen COO | 612 | $28.04 | $17,160 | 9,812 (Direct) | View |
| 2020-02-20 Sale | 2020-02-24 4:53 pm | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO | 360 | $29.68 | $10,685 | 6,120 (Direct) | View |
| 2020-04-26 Sale | 2020-04-28 1:43 pm | UroGen Pharma Ltd. | URGN | Mullennix Stephen COO | 145 | $24.35 | $3,531 | 10,084 (Direct) | View |
| 2020-04-26 Sale | 2020-04-28 1:51 pm | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO | 141 | $24.35 | $3,433 | 6,396 (Direct) | View |
| 2020-04-26 Sale | 2020-04-28 1:53 pm | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 70 | $24.35 | $1,705 | 17,711 (Direct) | View |
| 2020-05-20 Sale | 2020-05-20 4:44 pm | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO | 358 | $25.07 | $8,975 | 7,079 (Direct) | View |
| 2020-06-04 Sale | 2020-06-05 2:31 pm | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 349 | $27.51 | $9,602 | 18,404 (Direct) | View |
| 2020-07-26 Sale | 2020-07-28 5:32 pm | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 70 | $23.51 | $1,646 | 18,543 (Direct) | View |
| 2020-07-26 Sale | 2020-07-28 5:34 pm | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO | 141 | $23.51 | $3,315 | 7,355 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-06-03 Option Award | 2019-06-05 4:58 pm | N/A 2029-06-02 | UroGen Pharma Ltd. | URGN | BUTITTA CYNTHIA M Director | 10,000 | $34.83 | 10,000 (Direct) | View |
| 2019-06-03 Option Award | 2019-06-05 4:59 pm | N/A 2029-06-02 | UroGen Pharma Ltd. | URGN | FALBERG KATHRYN E Director | 10,000 | $34.83 | 10,000 (Direct) | View |
| 2019-06-03 Option Award | 2019-06-05 5:02 pm | N/A 2029-06-02 | UroGen Pharma Ltd. | URGN | Tomasello Shawn Director | 10,000 | $34.83 | 10,000 (Direct) | View |
| 2019-06-04 Exercise | 2019-06-06 6:21 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 1,042 | $0 | 6,250 (Direct) | View |
| 2019-06-04 Tax Withholding | 2019-06-06 6:21 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 343 | $35.05 | 6,250 (Direct) | View |
| 2019-06-04 Exercise | 2019-06-06 6:21 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 1,042 | $0 | 6,250 (Direct) | View |
| 2019-08-14 Exercise | 2019-08-16 3:38 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Mullennix Stephen COO | 1,759 | $0 | 6,532 (Direct) | View |
| 2019-08-14 Exercise | 2019-08-16 3:38 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Mullennix Stephen COO | 1,759 | $0 | 6,532 (Direct) | View |
| 2019-08-20 Exercise | 2019-08-22 1:31 pm | N/A N/A | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO | 4,167 | $0 | 2,751 (Direct) | View |
| 2019-08-20 Exercise | 2019-08-22 1:31 pm | N/A N/A | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO | 4,167 | $0 | 2,751 (Direct) | View |
| 2019-09-04 Exercise | 2019-09-06 09:27 am | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 1,041 | $0 | 6,007 (Direct) | View |
| 2019-09-04 Exercise | 2019-09-06 09:27 am | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 1,041 | $0 | 6,007 (Direct) | View |
| 2019-11-14 Exercise | 2019-11-18 4:04 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Mullennix Stephen COO | 1,759 | $0 | 7,683 (Direct) | View |
| 2019-11-14 Exercise | 2019-11-18 4:04 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Mullennix Stephen COO | 1,759 | $0 | 7,683 (Direct) | View |
| 2019-11-20 Exercise | 2019-11-22 1:29 pm | N/A N/A | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO | 1,042 | $0 | 3,439 (Direct) | View |
| 2019-11-20 Exercise | 2019-11-22 1:29 pm | N/A N/A | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO | 1,042 | $0 | 3,439 (Direct) | View |
| 2019-12-04 Exercise | 2019-12-05 1:44 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 1,042 | $0 | 4,167 (Direct) | View |
| 2019-12-04 Tax Withholding | 2019-12-05 1:44 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 343 | $31.69 | 4,167 (Direct) | View |
| 2019-12-04 Exercise | 2019-12-05 1:44 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 1,042 | $0 | 4,167 (Direct) | View |
| 2020-01-03 Exercise | 2020-01-07 6:30 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. CEO | 105,688 | $0 | 211,377 (Direct) | View |
| 2020-01-03 Exercise | 2020-01-07 6:30 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. CEO | 105,688 | $0 | 211,377 (Direct) | View |
| 2020-01-26 Exercise | 2020-01-28 5:10 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 833 | $0 | 9,177 (Direct) | View |
| 2020-01-26 Exercise | 2020-01-28 5:10 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 833 | $0 | 9,177 (Direct) | View |
| 2020-01-26 Exercise | 2020-01-28 5:14 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Mullennix Stephen COO | 1,666 | $0 | 8,665 (Direct) | View |
| 2020-01-26 Exercise | 2020-01-28 5:14 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Mullennix Stephen COO | 1,666 | $0 | 8,665 (Direct) | View |
| 2020-01-26 Exercise | 2020-01-28 5:15 pm | N/A N/A | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO | 1,666 | $0 | 4,438 (Direct) | View |
| 2020-01-26 Exercise | 2020-01-28 5:15 pm | N/A N/A | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO | 1,666 | $0 | 4,438 (Direct) | View |
| 2020-01-31 Option Award | 2020-02-04 12:36 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. CEO | 45,000 | $29.41 | 15,000 (Direct) | View |
| 2020-01-31 Option Award | 2020-02-04 12:36 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. CEO | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-01-31 Option Award | 2020-02-04 12:38 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 15,000 | $29.41 | 6,000 (Direct) | View |
| 2020-01-31 Option Award | 2020-02-04 12:38 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 6,000 | $0 | 6,000 (Direct) | View |
| 2020-01-31 Option Award | 2020-02-04 12:39 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Mullennix Stephen COO | 15,000 | $29.41 | 3,000 (Direct) | View |
| 2020-01-31 Option Award | 2020-02-04 12:39 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Mullennix Stephen COO | 3,000 | $0 | 3,000 (Direct) | View |
| 2020-01-31 Option Award | 2020-02-04 12:40 pm | N/A N/A | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO | 15,000 | $29.41 | 6,000 (Direct) | View |
| 2020-01-31 Option Award | 2020-02-04 12:40 pm | N/A N/A | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO | 6,000 | $0 | 6,000 (Direct) | View |
| 2020-02-14 Exercise | 2020-02-18 2:33 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Mullennix Stephen COO | 1,759 | $0 | 9,812 (Direct) | View |
| 2020-02-14 Exercise | 2020-02-18 2:33 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Mullennix Stephen COO | 1,759 | $0 | 9,812 (Direct) | View |
| 2020-02-20 Exercise | 2020-02-24 4:53 pm | N/A N/A | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO | 1,042 | $0 | 6,120 (Direct) | View |
| 2020-02-20 Exercise | 2020-02-24 4:53 pm | N/A N/A | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO | 1,042 | $0 | 6,120 (Direct) | View |
| 2020-03-04 Exercise | 2020-03-04 5:28 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 1,042 | $0 | 3,125 (Direct) | View |
| 2020-03-04 Tax Withholding | 2020-03-04 5:28 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 345 | $29.5 | 3,125 (Direct) | View |
| 2020-03-04 Exercise | 2020-03-04 5:28 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 1,042 | $0 | 3,125 (Direct) | View |
| 2020-04-26 Exercise | 2020-04-28 1:43 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Mullennix Stephen COO | 417 | $0 | 10,084 (Direct) | View |
| 2020-04-26 Exercise | 2020-04-28 1:43 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Mullennix Stephen COO | 417 | $0 | 10,084 (Direct) | View |
| 2020-04-26 Exercise | 2020-04-28 1:51 pm | N/A N/A | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO | 417 | $0 | 6,396 (Direct) | View |
| 2020-04-26 Exercise | 2020-04-28 1:51 pm | N/A N/A | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO | 417 | $0 | 6,396 (Direct) | View |
| 2020-04-26 Exercise | 2020-04-28 1:53 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 208 | $0 | 17,711 (Direct) | View |
| 2020-04-26 Exercise | 2020-04-28 1:53 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 208 | $0 | 17,711 (Direct) | View |
| 2020-05-12 Exercise | 2020-05-14 1:07 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. CEO | 35,229 | $0 | 176,148 (Direct) | View |
| 2020-05-12 Exercise | 2020-05-14 1:07 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. CEO | 35,229 | $0 | 176,148 (Direct) | View |
| 2020-05-20 Exercise | 2020-05-20 4:44 pm | N/A N/A | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO | 1,041 | $0 | 7,079 (Direct) | View |
| 2020-05-20 Exercise | 2020-05-20 4:44 pm | N/A N/A | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO | 1,041 | $0 | 7,079 (Direct) | View |
| 2020-06-04 Exercise | 2020-06-05 2:31 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 1,042 | $0 | 18,404 (Direct) | View |
| 2020-06-04 Exercise | 2020-06-05 2:31 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 1,042 | $0 | 18,404 (Direct) | View |
| 2020-06-08 Option Award | 2020-06-10 6:35 pm | N/A 2030-06-07 | UroGen Pharma Ltd. | URGN | Belldegrun Arie Director | 10,000 | $28.24 | 10,000 (Direct) | View |
| 2020-06-08 Option Award | 2020-06-10 6:36 pm | N/A 2030-06-07 | UroGen Pharma Ltd. | URGN | BUTITTA CYNTHIA M Director | 10,000 | $28.24 | 10,000 (Direct) | View |
| 2020-06-08 Option Award | 2020-06-10 6:38 pm | N/A 2030-06-07 | UroGen Pharma Ltd. | URGN | Cohen Fred E Director | 10,000 | $28.24 | 10,000 (Direct) | View |
| 2020-06-08 Option Award | 2020-06-10 6:39 pm | N/A 2030-06-07 | UroGen Pharma Ltd. | URGN | FALBERG KATHRYN E Director | 10,000 | $28.24 | 10,000 (Direct) | View |
| 2020-06-08 Option Award | 2020-06-10 6:40 pm | N/A 2030-06-07 | UroGen Pharma Ltd. | URGN | Holden Stuart Director | 10,000 | $28.24 | 10,000 (Direct) | View |
| 2020-06-08 Option Award | 2020-06-10 6:41 pm | N/A 2030-06-07 | UroGen Pharma Ltd. | URGN | Nussbaum Ran Director | 10,000 | $28.24 | 10,000 (Direct) | View |
| 2020-06-08 Option Award | 2020-06-10 6:43 pm | N/A 2030-06-07 | UroGen Pharma Ltd. | URGN | Tomasello Shawn Director | 10,000 | $28.24 | 10,000 (Direct) | View |
| 2020-07-26 Exercise | 2020-07-28 5:32 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 209 | $0 | 18,543 (Direct) | View |
| 2020-07-26 Exercise | 2020-07-28 5:32 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 209 | $0 | 18,543 (Direct) | View |
| 2020-07-26 Exercise | 2020-07-28 5:34 pm | N/A N/A | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO | 417 | $0 | 7,355 (Direct) | View |
| 2020-07-26 Exercise | 2020-07-28 5:34 pm | N/A N/A | UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO | 417 | $0 | 7,355 (Direct) | View |